logo

For the Inventor, By the Inventor

Atlanta, GA, United States of America

Luigi G Marzilli

This inventor holds 8 USPTO granted patents. Top assignees: Emory University, The Georgia State University Research Foundation, Inc., Warner-Lambert Company. Active years: 1990-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Luigi G Marzilli. Retrieved from https://idiyas.com/inventor/luigi-g-marzilli

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 8

% Patents Active = 100.0

Average Co-Inventor Count = 3.2

ph-index = 5

Forward Citations = 123(Granted Patents)


Location History:

  • Atlanta, GA (US) (1990 - 1999)
  • Baton Rouge, LA (US) (2015)

Company Filing History:

goldMedal6 out of 1,026 
 
Emory University
 patents
silverMedal3 out of 205 
 
The Georgia State University Research Foundation, Inc.
 patents
bronzeMedal1 out of 2,538 
 
Warner-Lambert Company
 patents
4. 1 out of 834,601 
Other
 patents
where one patent can have more than one assignee

Years Active: 1990-2015

Loading Chart...
8 patents (USPTO):Explore Patents
1. 9061077 - Methods of determining renal function using technetium-99m tricarbonyl-nitrilotriacetic acid (2015-06-23),
2. 5986074 - Metal chelates as pharmaceutical imaging agents, processes of making (1999-11-16),
3. 5955053 - Metal chelates as pharmaceutical imaging agents, processes of making (1999-09-21),
4. 5281616 - Porphyrin and phthalocyanine antiviral compositions (1994-01-25),
5. 5192788 - Porphyrin antiviral compositions (1993-03-09),
6. 5116831 - Aminoalkyl-substituted cycloalkylamine platinum (II) complexes (1992-05-26),
7. 5109016 - Method for inhibiting infection or replication of human immunodeficiency (1992-04-28),
8. 4970324 - Aminoalkyl-substituted azetidine platinum(II) complexes (1990-11-13),

Title: Luigi G Marzilli: Innovator in Renal Imaging Technologies

Introduction

Luigi G Marzilli is a prominent inventor based in Atlanta, GA, known for his significant contributions to the field of renal imaging technologies. With a total of 8 patents, Marzilli has developed innovative methods that enhance the understanding and measurement of renal function.

Latest Patents

One of his latest patents is titled "Methods of determining renal function using technetium-99m tricarbonyl-nitrilotriacetic acid." This invention relates to imaging the kidneys and measuring renal function using the renal tracer Tc(CO)(NTA). The methods encompass renal scintigraphy, which involves administering a renal tracer to an animal or human subject and quantitatively detecting the tracer in biological samples. Another notable patent is focused on "Metal chelates as pharmaceutical imaging agents, processes of making." This invention introduces novel metal chelates, such as technetium-99m or rhenium chelates, and outlines the processes for preparing these chelates from corresponding ligands. These advancements are crucial for renal imaging and the examination of renal function.

Career Highlights

Throughout his career, Marzilli has worked with esteemed institutions, including Emory University and Georgia State University Research Foundation, Inc. His work has significantly impacted the field of medical imaging, particularly in renal diagnostics.

Collaborations

Marzilli has collaborated with notable professionals in his field, including Dabney W Dixon and Raymond F Schinazi. These collaborations have furthered the development of innovative technologies in renal imaging.

Conclusion

Luigi G Marzilli's contributions to renal imaging technologies through his patents and collaborations highlight his role as a leading inventor in this specialized field. His work continues to influence advancements in medical diagnostics and patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…